| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
51,175 |
46,790 |
$1.82M |
| Z7502 |
|
7,379 |
7,257 |
$279K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,839 |
2,720 |
$264K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,271 |
6,769 |
$252K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,173 |
10,316 |
$206K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
4,909 |
4,311 |
$181K |
| 80053 |
Comprehensive metabolic panel |
21,951 |
20,479 |
$164K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,435 |
5,703 |
$156K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,281 |
2,127 |
$147K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,662 |
3,573 |
$136K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
25,097 |
23,283 |
$135K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,053 |
2,883 |
$130K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,228 |
1,190 |
$112K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
665 |
631 |
$106K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,907 |
2,780 |
$104K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,614 |
4,271 |
$97K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
352 |
329 |
$96K |
| 71045 |
Radiologic examination, chest; single view |
10,450 |
9,855 |
$95K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,499 |
2,331 |
$93K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,690 |
4,204 |
$74K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,250 |
4,912 |
$71K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,998 |
1,784 |
$67K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,190 |
2,017 |
$64K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,065 |
2,776 |
$42K |
| 84484 |
|
5,312 |
4,731 |
$34K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,800 |
1,719 |
$33K |
| 0250 |
|
5,642 |
4,435 |
$33K |
| 99199 |
Unlisted special service, procedure or report |
1,415 |
1,302 |
$31K |
| 83690 |
|
6,952 |
6,476 |
$30K |
| 83880 |
|
2,488 |
2,306 |
$30K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,538 |
5,025 |
$24K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,614 |
4,145 |
$24K |
| J3490 |
Unclassified drugs |
4,605 |
3,552 |
$20K |
| 96376 |
|
1,361 |
1,115 |
$20K |
| 81025 |
|
5,608 |
5,263 |
$20K |
| 0760 |
|
834 |
700 |
$20K |
| 83605 |
|
2,628 |
2,385 |
$19K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
176 |
173 |
$19K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,486 |
3,140 |
$16K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,564 |
2,172 |
$15K |
| 81001 |
|
5,975 |
5,663 |
$13K |
| 87040 |
|
1,450 |
1,214 |
$13K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,036 |
2,633 |
$12K |
| 0270 |
|
1,671 |
1,214 |
$12K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,738 |
1,638 |
$11K |
| 87088 |
|
2,796 |
2,641 |
$10K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
574 |
559 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
702 |
605 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
599 |
577 |
$8K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
582 |
561 |
$8K |
| 99221 |
|
446 |
381 |
$7K |
| 85610 |
|
3,061 |
2,870 |
$7K |
| 85027 |
|
1,972 |
1,782 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
437 |
421 |
$7K |
| 81002 |
|
3,689 |
3,486 |
$6K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
193 |
186 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,278 |
1,200 |
$6K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
156 |
153 |
$5K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
61 |
60 |
$5K |
| 85379 |
|
808 |
770 |
$4K |
| 73562 |
|
308 |
285 |
$4K |
| 85730 |
|
1,254 |
1,169 |
$4K |
| 87077 |
|
1,036 |
988 |
$4K |
| 73610 |
|
183 |
168 |
$4K |
| 73630 |
|
181 |
174 |
$3K |
| J2060 |
Injection, lorazepam, 2 mg |
943 |
813 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
66 |
65 |
$3K |
| 90715 |
|
130 |
127 |
$3K |
| 73130 |
|
198 |
189 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
600 |
557 |
$2K |
| 93971 |
|
65 |
64 |
$2K |
| 81003 |
|
1,936 |
1,852 |
$2K |
| G0378 |
Hospital observation service, per hour |
19 |
12 |
$2K |
| 87186 |
|
369 |
357 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
154 |
131 |
$1K |
| 82962 |
|
315 |
253 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
59 |
57 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
345 |
315 |
$1K |
| 0324 |
|
77 |
73 |
$1K |
| 0301 |
|
30 |
25 |
$1K |
| 83735 |
|
382 |
340 |
$980.06 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
60 |
56 |
$977.68 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
197 |
192 |
$973.85 |
| 84702 |
|
132 |
119 |
$895.97 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
217 |
211 |
$879.03 |
| 84703 |
|
150 |
134 |
$827.46 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
153 |
139 |
$816.55 |
| 85007 |
|
414 |
390 |
$767.93 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
27 |
26 |
$763.41 |
| 80329 |
|
84 |
75 |
$728.74 |
| 80320 |
|
262 |
221 |
$577.55 |
| Z7610 |
|
34 |
27 |
$573.75 |
| 86901 |
|
244 |
225 |
$569.55 |
| 86900 |
|
253 |
236 |
$535.90 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
184 |
170 |
$462.13 |
| 73110 |
|
27 |
26 |
$422.45 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
98 |
89 |
$401.68 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
25 |
25 |
$339.09 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
66 |
58 |
$310.75 |
| 0637 |
|
377 |
288 |
$304.20 |
| 87400 |
|
137 |
130 |
$294.01 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
238 |
205 |
$258.91 |
| 96368 |
|
14 |
12 |
$257.80 |
| 73030 |
|
27 |
26 |
$192.53 |
| 0272 |
|
854 |
817 |
$116.12 |
| A4649 |
Surgical supply; miscellaneous |
297 |
211 |
$109.26 |
| 0206 |
|
12 |
12 |
$77.54 |
| J1630 |
Injection, haloperidol, up to 5 mg |
30 |
25 |
$77.27 |
| 96367 |
|
12 |
12 |
$70.03 |
| 87070 |
|
12 |
12 |
$69.36 |
| 0271 |
|
836 |
810 |
$57.62 |
| 87081 |
|
13 |
13 |
$52.17 |
| C9113 |
Injection, pantoprazole sodium, per vial |
31 |
26 |
$19.42 |
| 86850 |
|
12 |
12 |
$18.09 |
| J2471 |
Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg |
19 |
16 |
$16.55 |
| 0636 |
|
17 |
15 |
$2.26 |
| 0305 |
|
12 |
12 |
$0.00 |
| 0306 |
|
12 |
12 |
$0.00 |